New research examined whether levels of prenatal estriol, estradiol, estrone, and estrone sulphate in amniotic fluid are associated with autism.
©zffoto/shutterstock.com
High levels of latent prenatal steroidogenic activity have been found in the amniotic fluid of autistic boys, but it remains unclear if other prenatal steroids also contribute to risk of autism. A recent study inNature examined whether levels of prenatal estriol, estradiol, estrone, and estrone sulphate in amniotic fluid are associated with autism.
Participants in the study were 98 boys with autism and 177 controls from the Danish Historic Birth Cohort born between 1993 and 1999. All had amniotic fluid samples corresponding to amniocentesis procedures performed between 14 and 16 weeks of gestational age. The authors assayed the samples for estriol, estradiol, estrone, and estrone sulphate using liquid chromatography-tandem mass spectroscopy.
No significant differences were found between the groups in maternal age at birth, paternal age at birth, birth weight, gestational week at amniocentesis or storage time. However, univariate logistic regression showed that higher estradiol levels were the most predictive of an autism diagnosis (Ã = 0.029, Benjamini-Hochberg false discovery rate [FDR]-adjusted q = 0.031). Estriol and estrone levels also were significantly associated with autism diagnosis (estriol: Ã = 0.025, FDR-adjusted q =0.034; estrone: Ã = 0.029; FDR-adjusted q = 0.031). Estrone sulphate was nominally significant but did not maintain statistical significance following false discovery rate correction.
When examining androgens and cortisol in the same subset of samples, only progesterone was a significant predictor of autism diagnosis, following univariate logistic regression and correction via FDR (Ã = 0.053, FDR-adjusted q = 0.031).
The authors believe this study provides the first evidence that elevated levels of prenatal amniotic estradiol, estriol, and estrone are associated with autism, although estradiol levels were the most significant predictor in univariate logistic regression models. Ob/gyns may want to consider counseling women with higher levels of prenatal estradiol on the associated risks.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More